Evaluation of patient adherence with oral anticancer agents

被引:0
|
作者
Kazaz, Seher Nazli [1 ]
Yildirim, Atila [1 ]
机构
[1] Karadeniz Tech Univ, Sch Med, Dept Med Oncol, Trabzon, Turkiye
关键词
Adherence; cancer; modified medication adherence scale-6; modified morisky scale; oral anticancer drugs; MEDICATION ADHERENCE; THERAPY; OUTCOMES; INTERVENTIONS; NONADHERENCE; MANAGEMENT; DURATION; IMATINIB;
D O I
10.4103/jcrt.jcrt_2238_22
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background:The aim of the study was to measure the adherence to oral anticancer treatments in cancer patients using the Modified Morisky Scale (Modified Medication Adherence Scale 6) which has been shown to be valid and reliable in Turkish. Methods:This study was an observational, single-center study involving 300 cancer patients receiving various oral anticancer agents admitted to our outpatient clinic. Motivation and knowledge scores were calculated as per the Modified Medication Adherence Scale 6. Results:The motivation and knowledge levels of the population aged less than 65 years were found to be significantly higher than the geriatric population (>= 65 years old) (P < .003 and P< .001, respectively). It was observed that the patients with higher education levels had significantly higher motivation and knowledge levels (P < .0001 for both). There was no correlation between the motivation and knowledge levels of the patients with gender, marital status, living status, and stage of the disease (P > .05). In addition, the duration of drug use >12 months and the cyclical use of drugs were also found to be significantly associated with increased motivation and knowledge levels. Conclusion:Identifying adherence and related factors, informing patients in detail about the efficacy and toxicity of treatments are the simplest and most basic methods. Particular attention should be paid to patients aged > 65 years, patients with a low level of education, and patients in the earlier stages of their treatments.
引用
收藏
页码:1707 / 1712
页数:6
相关论文
共 50 条
  • [41] Investigation of benzimidazole anthelmintics as oral anticancer agents
    Jang, Jiyoon
    Lee, Kwangho
    Koh, Byumseok
    BULLETIN OF THE KOREAN CHEMICAL SOCIETY, 2022, 43 (05) : 750 - 756
  • [42] Oral Formulation of Anticancer Agents for Colon Cancer
    Patel, Dipti
    Patel, Krishna
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (46B) : 402 - 418
  • [43] Efficacy of oral anticancer agents for colorectal cancer
    Sakamoto, Junichi
    Oba, Koji
    Matsui, Takanori
    Kobayashi, Michiya
    DISEASES OF THE COLON & RECTUM, 2006, 49 (10) : S82 - S91
  • [44] The Association Between Patient-Reported and Objective Oral Anticancer Medication Adherence Measures: A Systematic Review
    Atkinson, Thomas M.
    Rodriguez, Vivian M.
    Gordon, Mallorie
    Avildsen, Isabelle K.
    Emanu, Jessica C.
    Jewell, Sarah T.
    Anselmi, Kimberly A.
    Ginex, Pamela K.
    ONCOLOGY NURSING FORUM, 2016, 43 (05) : 576 - 582
  • [45] Pharmacokinetically Based Estimation of Patient Compliance with Oral Anticancer ChemotherapiesIn Silico Evaluation
    Emilie Hénin
    Michel Tod
    Véronique Trillet-Lenoir
    Catherine Rioufol
    Brigitte Tranchand
    Pascal Girard
    Clinical Pharmacokinetics, 2009, 48 : 359 - 369
  • [46] Patient reported medication-related problems, adherence and waste of oral anticancer medication over time
    van den Bemt, Patricia M. L. A.
    Blijham, Margriet Y.
    ten Broek, Laura
    Hugtenburg, Jacqueline G.
    Pouls, Bart P. H.
    van Boven, Job F. M.
    Bekker, Charlotte L.
    van den Bemt, Bart
    van Dijk, Liset
    EUROPEAN JOURNAL OF HOSPITAL PHARMACY, 2024,
  • [47] Pharmacokinetically Based Estimation of Patient Compliance with Oral Anticancer Chemotherapies In Silico Evaluation
    Henin, Emilie
    Tod, Michel
    Trillet-Lenoir, Veronique
    Rioufol, Catherine
    Tranchand, Brigitte
    Girard, Pascal
    CLINICAL PHARMACOKINETICS, 2009, 48 (06) : 359 - 369
  • [48] Patient education outcomes in patients receiving oral anticancer agents: Preliminary results of a systematic review
    Cadorin, L.
    Cedrone, S.
    Sartor, I.
    Fonda, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S1243 - S1243
  • [49] Comorbidity and Adherence to Oral Antihyperglycemic Agents in Ireland
    O'Shea, Miriam P.
    Teeling, Mary
    Bennett, Kathleen
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 284 - 284
  • [50] EVALUATION OF BIOREDUCTIVE ANTICANCER AGENTS INVIVO
    COLE, S
    EDWARDS, H
    BREMNER, JCM
    STRATFORD, IJ
    BRITISH JOURNAL OF CANCER, 1990, 62 (03) : 515 - 515